43.48% 2.862

Glucotrack Inc (GCTK)

概要ニュース株価時系列 Financials ディスカッション予測株式分割

Relative Volume:

ネットキャッシュフロー:

Glucotrack Inc Stock (GCTK) Company Profile

Glucotrack Inc

Healthcare (1171)

972 (8) 675-7878

301 RT 17 NORTH, RUTHERFORD

GCTK's Discussions on Twitter

GCTK を他の銘柄と比較する

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
GCTK Glucotrack Inc	9.06	4.50M	0	-8.74M	-8.25M	-2.05
ISRG Intuitive Surgical Inc	522.01	189.82B	8.71B	2.48B	1.75B	6.82
BDX Becton Dickinson Co	170.54	49.98B	20.87B	1.50B	2.59B	5.24
ALC Alcon Inc	87.39	44.00B	9.93B	1.12B	1.58B	2.25
RMD Resmed Inc	258.28	37.05B	5.02B	1.31B	1.56B	8.91
WST West Pharmaceutical Services Inc	221.08	16.36B	2.90B	467.20M	306.90M	6.37

Glucotrack Inc (GCTK) 最新ニュース

Glucotrack Inc (GCTK) 財務データ

Glucotrack Inc (GCTK)

Glucotrack Inc Stock (GCTK) Company Profile

GCTK を他の銘柄と比較する

Glucotrack Inc (GCTK) 最新ニュース

Glucotrack announces 1:60 reverse stock split - Investing.com

GlucoTrack Implements Reverse Stock Split - TipRanks

Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements - mx.advfn.com

Glucotrack announces 1-for-60 reverse stock split effective June 16 By Investing.com - Investing.com South Africa

Glucotrack announces 1-for-60 reverse stock split effective June 16 - Investing.com Nigeria

GlucoTrack Announces 1-for-60 Reverse Stock Split - TipRanks

Glucotrack Implements Major 1-for-60 Reverse Split: What This Means for Your Investment - Stock Titan

Glucotrack’s Innovative Approach to Diabetes Management Sets New Standards - citybuzz -

Rebuilding Trust: How Glucotrack Is Establishing A New Standard In Diabetes Management - Nasdaq

Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions - mx.advfn.com

GlucoTrack to Present at ADA Scientific Sessions - TipRanks

Revolutionary Diabetes Tech: Glucotrack's 3-Year Implantable Monitor Eliminates Daily Finger Pricks - Stock Titan

GCTK stock plunges to 52-week low, hits $0.13 By Investing.com - Investing.com South Africa

GCTK stock plunges to 52-week low, hits $0.13 - Investing.com India

Upcoming Benzinga Webinar With Glucotrack To Discuss The Potential Of Its Innovative CBGM Technology To Transform Diabetes Care And Patient Lives - The Globe and Mail

Glucotrack appoints new board member with diabetes tech expertise By Investing.com - Investing.com South Africa

Glucotrack appoints new board member with diabetes tech expertise - Investing.com

Glucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD - The Manila Times

GlucoTrack (NASDAQ:GCTK) Trading Down 0.2% – Time to Sell? - Defense World

GlucoTrack Approves Key Proposals at Annual Meeting - TipRanks

GCTK stock plunges to 52-week low, touches $0.13 - Investing.com Australia

GCTK stock plunges to 52-week low, touches $0.13 By Investing.com - Investing.com Nigeria

GlucoTrack Establishes Patient Advisory Board for CBGM - TipRanks

Glucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development - The Manila Times

Glucotrack, Inc. Forms Patient Advisory Board to Enhance Development of Continuous Blood Glucose Monitor - Nasdaq

Groundbreaking 3-Year Implantable Glucose Monitor Gets Patient-Led Development at Glucotrack - Stock Titan

Glucotrack Reports Q1 2025 Financial Results and Progress - TipRanks

Glucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - The Manila Times

Innovative Continuous Blood Glucose Monitor Shows Promise in First Human Trial - citybuzz -

GlucoTrack Reports Q1 2025 Financial Results and Progress - TipRanks

Glucotrack, Inc. SEC 10-Q Report - TradingView

Glucotrack, Inc. Advances Continuous Blood Glucose Monitoring Technology with Clinical Study Initiation in Australia by Q3 2025 - Nasdaq

Glucotrack Reports First Quarter 2025 Financial Results And Recent Corporate Highlights - marketscreener.com

Breakthrough: Glucotrack's Implantable Diabetes Monitor Hits Clinical Milestone, FDA Decision Expected Q4 - Stock Titan

Glucotrack gains HREC approval for clinical study of CBGM device - Yahoo Finance

First-In-Human Study In The Bag, Glucotrack Gears Up For Long-Term Trial Of Potentially Groundbreaking Continuous Blood Glucose Monitor For Diabetes Patients - FinancialContent

Certain Options of GlucoTrack, Inc. are subject to a Lock-Up Agreement Ending on 14-MAY-2025. - marketscreener.com

Certain Common Stock of GlucoTrack, Inc. are subject to a Lock-Up Agreement Ending on 14-MAY-2025. - marketscreener.com

GlucoTrack Gains Approval for Long-Term Clinical Study - TipRanks

Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor - The Manila Times

Geode Capital Management LLC Increases Stock Holdings in GlucoTrack, Inc. (NASDAQ:GCTK) - Defense World

GlucoTrack Inc (GCTK) can make a big difference with a little luck - Sete News

Medtech CEO Shares Lessons From FIH Implantable Glucose Monitor Trial - Clinical Leader

GlucoTrack Releases Investor Presentation on April 29 - TipRanks

GlucoTrack Inc (NASDAQ:GCTK) stock crossing the finish line today - uspostnews.com

Can GlucoTrack Inc Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com

Now Is The Time To Build A Position In GlucoTrack Inc (NASDAQ:GCTK) - Marketing Sentinel

Glucotrack Inc (GCTK) 財務データ

収益

当期純利益

現金流量

EPS

GCTKに似た銘柄